Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|May 9, 2015
Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cellsEva M Weissinger, Sylvia Borchers, Anna Silvani, et al.
Annals of Hematology|April 11, 2012
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromesFelicitas Thol, Haiyang Yun, Ann-Kathrin Sonntag, et al.
Cytotherapy|August 29, 2020
Cell culture media notably influence properties of human mesenchymal stroma/stem-like cells from different tissuesAndreas Winkel, Yarúa Jaimes, Catharina Melzer, et al.
Leukemia|July 12, 2013
Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantationE M Weissinger, J Metzger, C Dobbelstein, et al.
Leukemia|September 29, 2016
The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantationE M Weissinger, C Human, J Metzger, et al.
Leukemia|January 17, 2017
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCTM Neuenhahn, J Albrecht, M Odendahl, et al.
Proteomics. Clinical Applications|February 5, 2010
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsJoshua J Coon, Petra Zürbig, Mohammed Dakna, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
Pageof 12